These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1020408)

  • 1. [The 131I-fibrinogen turnover during activation of blood fibrinolysis].
    Grabowski R; Bielawiec M; Kiersnowska B; Lukjan H; Perzanowski A; Mysliwiec M; Korfel B; Rogowski F
    Z Gesamte Inn Med; 1976 Dec; 31(24):1025-7. PubMed ID: 1020408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis of recurrent venous thrombosis with long-term enhancement of fibrinolysis.
    Bielawiec M; Lukjan H; Myśliwiec M; Dabrowski S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):971-6. PubMed ID: 94894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of phenformin plus stanozolol on fibrinolysis, platelet adhesiveness and blood lipids in patients with recurrent venous thrombosis.
    Bielawiec M; Myśliwiec M; Perzanowski A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):483-8. PubMed ID: 4139068
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical investigations on long-term activation of fibrinolysis by anabolic steroids.
    Bielawiec M; Bodzenta A; Lukjan H; Kiersnowska-Rogowska B; Kłoczko J; Myśliwiec M; Dabrowski S; Tymiński W; Czestochowska E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):223-9. PubMed ID: 2427405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic recurrent superficial thrombophlebitis: treatment with fibrinolytic enhancement.
    Jarrett PE; Morland M; Browse NL
    Br Med J; 1977 Apr; 1(6066):933-4. PubMed ID: 856391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
    Menon IS
    Acta Univ Carol Med Monogr; 1972; 52():19-23. PubMed ID: 4669824
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozolol.
    Belch JJ; Madhok R; McArdle B; McLaughlin K; Kluft C; Forbes CD; Sturrock RD
    Q J Med; 1986 Jan; 58(225):19-27. PubMed ID: 3517926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and laboratory double-blind investigation on effect of fibrinolytic therapy in patients with cutaneous vasculitis.
    Dodman B; Cunliffe WJ; Roberts BE; Sibbald R
    Br Med J; 1973 Apr; 2(5858):82-4. PubMed ID: 4573315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma fibrinolytic system and blood pressure in patients with hypertensive cardiovascular disease treated with reserpine and phenformin.
    Worowski K; Prokopowicz J; Gabryelewicz A
    Haematologia (Budap); 1970; 4(3):399-403. PubMed ID: 4256949
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of phenphormin on blood fibrinolysis in diabetes mellitus.
    Fiaschi E; Barbui T; Previato G; Di Luzio V; Guarnieri GF; Todesco S
    Arzneimittelforschung; 1969 Apr; 19(4):638-40. PubMed ID: 5819165
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of combined treatment with phenformin and stanazolol on blood lipids and fibrinolytic activity in patients with hypertriglyceridaemia.
    Ciświcka-Sznajderman M; Berent H; Rymaszewski Z
    Atherosclerosis; 1974; 19(1):153-9. PubMed ID: 4359182
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma beta-thromboglobulin, fibrinopeptide A and B beta 15-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment.
    Douglas JT; Blamey SL; Lowe GD; Carter DC; Forbes CD
    Thromb Haemost; 1985 Apr; 53(2):235-8. PubMed ID: 2410995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral stanozolol used in the prevention of postoperative deep vein thrombosis on fibrinolytic activity.
    Sue-Ling HM; Davies JA; Prentice CR; Verheijen JH; Kluft C
    Thromb Haemost; 1985 Feb; 53(1):141-2. PubMed ID: 3873118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of Complamin on fibrinolysis and platelet aggregation in the aged].
    Matijević N; Sisić I; Korolija P; Pendić B
    Bilt Hematol Transfuz; 1980; 8(1):37-43. PubMed ID: 7337681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of platelet adhesiveness by phenformin combined with ethylestrenol or stanozolol.
    Chakrabarti R
    Acta Univ Carol Med Monogr; 1972; 53():261-2. PubMed ID: 4670736
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of phenformin and stanozol administration on lipid metabolism in patients with occlusive vascular diseases].
    Perzanowski A; Bielawiec M; Myśliwiec M
    Pol Tyg Lek; 1972 Jan; 27(5):174-6. PubMed ID: 5010762
    [No Abstract]   [Full Text] [Related]  

  • 17. Stanozolol-induced changes in fibrinolysis and coagulation in healthy adults.
    Kluft C; Preston FE; Malia RG; Bertina RM; Wijngaards G; Greaves M; Verheijen JH; Dooijewaard G
    Thromb Haemost; 1984 Apr; 51(2):157-64. PubMed ID: 6740547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic enhancement by stanozolol: a double blind trial.
    Davidson JF; Lochhead M; McDonald GA; McNicol GP
    Br J Haematol; 1972 May; 22(5):543-59. PubMed ID: 4555715
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of complamin on the systemic and cerebral hemodynamics of atherosclerosis patients with chronic cerebral vascular disorders].
    Ishchenko MM; Dorogiĭ AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(1):59-65. PubMed ID: 3984595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of complamine, nonachlazine, riboxine and clofeline on the fibrinogen content and fibrinolytic activity of the blood].
    Kremneva VF; Shevchenko LV
    Farmakol Toksikol; 1980; 43(3):330-5. PubMed ID: 7449972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.